Q4 2024 Elevance Health Inc Earnings Call Transcript
Key Points
- Elevance Health Inc (ELV) reported fourth-quarter adjusted diluted earnings per share of $3.84, consistent with prior expectations.
- The company achieved strong member retention in its Medicare Advantage business, with anticipated membership growth of 7% to 9% for 2025.
- Elevance Health's commercial businesses performed well in 2024, with record retention in national accounts and strong growth in individual exchange business.
- The acquisition of CareBridge is expected to bolster home- and community-based services, aligning with the company's focus on whole health.
- Elevance Health plans to allocate approximately $2.3 billion towards share repurchases in 2025, demonstrating a commitment to returning capital to shareholders.
- Elevance Health experienced elevated cost trends in its Medicaid business, which remain a challenge due to insufficient rates to cover costs.
- The company reported a decrease of 1.1 million members year over year, primarily due to Medicaid redeterminations and geographic changes.
- Medicaid cost trends are expected to remain elevated in the first half of 2025, impacting margins until rate adjustments are fully reflected.
- The operating margin for health benefits is expected to decline by 25 to 50 basis points year over year in 2025.
- Elevance Health's Medicare Advantage margins are expected to remain below long-term targets despite anticipated stability in 2025.
Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth-quarter earnings conference call. (Operator Instructions)
As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.
Good morning, and welcome to Elevance Health's fourth-quarter 2024 earnings conference call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on the earnings call are Gail Boudreaux, President and CEO; Mark Kaye, CFO; Peter Haytaian, President of Carelon; Morgan Kendrick, President of our Commercial health benefits business; and Felicia Norwood, President of our Government health benefits business.
Gail will begin the call with a review of the progress we've made against our strategic initiatives and the discussion of the quarter and our 2025 outlook. Mark will then discuss our financial results and guidance in greater detail. After our prepared remarks
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
